RBOT

SEC source: 0001213900-22-067118 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,277,007

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-066058 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,887

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.07 to $3.23 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-065176 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,760

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.335 to $3.50 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-065033 · ownership.xml · nonDerivative · entry 3

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,012,534

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F5 · price: This figure is the weighted average sales price of multiple trades ranging from $3.38 to $3.65 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-065176 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333,760

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.38 to $3.65 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-065295 · ownership.xml · nonDerivative · entry 1

HUSS BEVERLY A · CIK 0001222352 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,982

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in equal monthly installments over three years following the date of grant, subject to the Reporting Person's continued service through the applicable vesting date.

SEC source: 0001213900-22-065033 · ownership.xml · derivative · entry 4

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,519,811

Underlying: Class A Common Stock · 4,551 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-065033 · ownership.xml · nonDerivative · entry 2

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,019,332

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.45 to $3.49 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-065033 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,023,883

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-061576 · ownership.xml · nonDerivative · entry 1

Ho David D · CIK 0001850976 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,209

F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $11,375 of cash retainer fees earned during the third quarter of 2022. The RSUs were fully vested on the grant date.

SEC source: 0001213900-22-061579 · ownership.xml · nonDerivative · entry 1

Kaul Samir · CIK 0001501915 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,232

F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $13,562 of cash retainer fees earned during the third quarter of 2022. The RSUs were fully vested on the grant date.

SEC source: 0001213900-22-061578 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,200,320

F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $12,538 of cash retainer fees earned during the third quarter of 2022. The RSUs were fully vested on the grant date.

SEC source: 0001213900-22-060161 · ownership.xml · nonDerivative · entry 3

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,265,678

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2021.

F5 · price: This figure is the weighted average sales price of multiple trades ranging from $3.33 to $3.52 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-060161 · ownership.xml · derivative · entry 4

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,261,721

Underlying: Class A Common Stock · 11,329 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-060161 · ownership.xml · nonDerivative · entry 2

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,274,175

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.34 to $3.50 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-060161 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,285,504

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-060167 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 334,387

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on December 14, 2021.

SEC source: 0001213900-22-076205 · ownership.xml · derivative · entry 4

Sachs Adam David · CIK 0001885593 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,239,063

Underlying: Class A Common Stock · 11,329 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-058108 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340,384

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.80 to $4.00 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · balance_after: Reflects a correction to the amount of shares beneficially held, which amount as provided in the Form 4 filed on September 7, 2022 reflected an error.

SEC source: 0001213900-22-058106 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,274,175

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.80 to $4.00 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · balance_after: Reflects a correction to the amount of shares beneficially held, which amount as provided in the Form 4s filed on August 29, 2022 and September 7, 2022 reflected an error.

SEC source: 0001213900-22-058107 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 336,632

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.80 to $4.00 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · balance_after: Reflects a correction to the amount of shares beneficially held, which amount as provided in the Form 4s filed on August 29, 2022 and September 7, 2022 reflected an error.

SEC source: 0001213900-22-058126 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,019,332

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.80 to $4.00 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-057220 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,196,577

F1 · price: This figure is the weighted average sales price of multiple trades ranging from $3.80 to $3.86 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-056591 · ownership.xml · derivative · entry 3

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,524,362

Underlying: Class A Common Stock · 4,551 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-056591 · ownership.xml · nonDerivative · entry 2

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,022,278

F3 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2022.

F4 · price: This figure is the weighted average sales price of multiple trades ranging from $4.16 to $4.20 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-056591 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,026,829

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F2 · balance_after: Reflects a correction to the amount of shares beneficially held, which amount as provided in the Form 4s filed on August 29, 2022 and September 7, 2022 reflected an error.

SEC source: 0001213900-22-056560 · ownership.xml · nonDerivative · entry 2

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,209,077

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $4.250 to $4.330 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-056560 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,214,777

F1 · price: This figure is the weighted average sales price of multiple trades ranging from $4.200 to $4.3037 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-055593 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,222,377

F1 · price: This figure is the weighted average sales price of multiple trades ranging from $4.410 to $4.534 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-055330 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,234,320

F1 · price: This figure is the weighted average sales price of multiple trades ranging from $4.400 to $4.5173 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-054627 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341,374

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.665 to $3.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-054625 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,277,867

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.665 to $3.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-054626 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 337,609

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.665 to $3.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-054628 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,022,289

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.665 to $3.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-053919 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341,505

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.59 to $3.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-053908 · ownership.xml · nonDerivative · entry 2

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,278,359

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.59 to $3.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-053910 · ownership.xml · nonDerivative · entry 2

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 337,739

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.59 to $3.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-053914 · ownership.xml · nonDerivative · entry 2

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,022,683

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.59 to $3.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-053919 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341,944

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.685 to $3.81 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-053908 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,280,005

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.685 to $3.81 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-053910 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,174

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.685 to $3.81 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-053914 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,023,999

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.685 to $3.81 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-052740 · ownership.xml · nonDerivative · entry 4

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,281,766

F4 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F6 · price: This figure is the weighted average sales price of multiple trades ranging from $3.73 to $3.90 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-052741 · ownership.xml · nonDerivative · entry 2

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 342,414

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.73 to $3.90 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-052738 · ownership.xml · nonDerivative · entry 2

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,639

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.73 to $3.90 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-052739 · ownership.xml · nonDerivative · entry 2

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,025,407

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.73 to $3.90 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-053075 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund Advisors (HK) Limited

Disclosed balance after: 300,001

F1 · kind: E15 Fund Advisors (HK) Limited distributed these shares to its members on a pro rata basis, for no consideration.

F2 · ownership.nature: Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-22-052740 · ownership.xml · derivative · entry 5

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,273,050

Underlying: Class A Common Stock · 11,329 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-052740 · ownership.xml · nonDerivative · entry 3

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,283,187

F4 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F5 · price: This figure is the weighted average sales price of multiple trades ranging from $3.80 to $3.89 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-052740 · ownership.xml · nonDerivative · entry 2

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,288,308

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.77 to $3.89 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.